ADVM Shares Outstanding History
Below is a table of the ADVM shares outstanding history going back to 7/31/2014:

Date ADVM Shares Outstanding

Also see: ADVM Market Cap History
ADVM Historical Shares Outstanding:
+25.82% CAGR
ADVM Historical Shares Outstanding: +25.82% CAGR

Mouse over chart for data details
7/31/2014 ...4/29/2021
Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Co. develops gene therapy product candidates designed to provide efficacy by inducing sustained expression of a therapeutic protein. Co.'s main capabilities include vector discovery, preclinical and clinical development, and in-house manufacturing knowledge, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control. Co.'s lead product candidate ADVM-022 is a single intravitreal injection gene therapy targeting the treatment of wet age-related macular degeneration and diabetic retinopathy. We show 29 historical shares outstanding datapoints in our coverage of ADVM's shares outstanding history.

Understanding the changing numbers of ADVM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADVM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADVM by allowing them to research ADVM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ADVM:
ADVM SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adverum Biotechnologies (ADVM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ADXS Shares Outstanding History
AEMD Shares Outstanding History
AERI Shares Outstanding History
AEZS Shares Outstanding History
AGEN Shares Outstanding History
AGIO Shares Outstanding History
AGLE Shares Outstanding History
AGN Shares Outstanding History
AGRX Shares Outstanding History
AGTC Shares Outstanding History
More Healthcare companies »


ADVM Shares Outstanding History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.